Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Diabetic Gastroparesis
Interventions
DRUG

IW-9179

DRUG

Matching Placebo

Trial Locations (22)

10018

Ironwood Investigational Site, New York

11023

Ironwood Investigational Site, Great Neck

12601

Ironwood Investigational Site, Poughkeepsie

27103

Ironwood Investigational Site, Winston-Salem

27410

Ironwood Investigational Site, Greensboro

33122

Ironwood Investigational Site, Miami

33607

Ironwood Investigational Site, Tampa

35203

Ironwood Investigational Site, Birmingham

36305

Ironwood Investigational Site, Dothan

37421

Ironwood Investigational Site, Chattanooga

48047

Ironwood Investigational Site, Chesterfield

55905

Ironwood Investigational Site, Rochester

61801

Ironwood Investigational Site, Urbana

71220

Ironwood Investigational Site, Bastrop

72117

Ironwood Investigational Site, North Little Rock

77015

Ironwood Investigational Site, Houston

77598

Ironwood Investigational Site, Webster

84405

Ironwood Investigational Site, Ogden

85710

Ironwood Investigational Site, Tucson

90036

Ironwood Investigational Site, Los Angeles

91910

Ironwood Investigational Site, Chula Vista

93003

Ironwood Investigational Site, Ventura

Sponsors
All Listed Sponsors
lead

Ironwood Pharmaceuticals, Inc.

INDUSTRY

NCT02289846 - Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP) | Biotech Hunter | Biotech Hunter